Literature DB >> 29934843

[Entrapment and non-entrapment syndromes at the elbow].

T Godel1, M Pham2.   

Abstract

CLINICAL/METHODICAL ISSUE: Entrapment syndromes of peripheral nerves at the elbow are common and are often diagnostically challenging disorders. Difficulties consist in lesion localization and recognition of complex spatial lesion patterns as well as in differentiation of focal and multifocal disorders. STANDARD DIAGNOSTIC
METHODS: Medical history taking, neurological examination and neurophysiological tests represent the gold standard in the diagnosis of peripheral nerve lesions at the elbow, but have known methodical limitations. METHODICAL INNOVATIONS: Additional diagnostic imaging tools recently developed for high-resolution visualization of extended peripheral nerve segments include 3 T magnetic resonance neurography (MRN) and neurosonography. PERFORMANCE: MRN and neurosonography can directly visualize and thus precisely localize focal and nonfocal peripheral nerve lesions of various origins with high spatial resolution at the anatomical level of nerve fascicles. ACHIEVEMENTS: MRN can cover peripheral nerve structures at the elbow, evaluate spatial nerve lesion patterns and partly disclose underlying causes. PRACTICAL RECOMMENDATIONS: Imaging of peripheral nerves is a valuable addition in the diagnostic work-up of entrapment syndromes at the elbow and provides important assistance in the differentiation of nonfocal differential diagnoses, especially in cases that cannot be clarified using standard diagnostic methods. The evaluation of spatial nerve lesion pattern may give additional information on the origin of the underlying disease, which is essential for further treatment.

Entities:  

Keywords:  Magnetic resonance imaging; Magnetic resonance neurography; Nerve imaging; Peripheral nervous system; Peripheral neuropathy

Mesh:

Year:  2018        PMID: 29934843     DOI: 10.1007/s00117-018-0417-1

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  8 in total

1.  Ulnar neuropathy at the elbow: MR neurography--nerve T2 signal increase and caliber.

Authors:  Philipp Bäumer; Thomas Dombert; Frank Staub; Thorsten Kaestel; Andreas J Bartsch; Sabine Heiland; Martin Bendszus; Mirko Pham
Journal:  Radiology       Date:  2011-04-14       Impact factor: 11.105

2.  [MR neurography for lesion localization in the peripheral nervous system. Why, when and how?].

Authors:  M Pham
Journal:  Nervenarzt       Date:  2014-02       Impact factor: 1.214

Review 3.  Technology insight: visualizing peripheral nerve injury using MRI.

Authors:  Martin Bendszus; Guido Stoll
Journal:  Nat Clin Pract Neurol       Date:  2005-11

4.  Thoracic outlet syndrome in 3T MR neurography-fibrous bands causing discernible lesions of the lower brachial plexus.

Authors:  P Baumer; H Kele; T Kretschmer; R Koenig; M Pedro; M Bendszus; M Pham
Journal:  Eur Radiol       Date:  2013-11-22       Impact factor: 5.315

5.  MR neurography in ulnar neuropathy as surrogate parameter for the presence of disseminated neuropathy.

Authors:  Philipp Bäumer; Markus Weiler; Maurice Ruetters; Frank Staub; Thomas Dombert; Sabine Heiland; Martin Bendszus; Mirko Pham
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

6.  Anterior interosseous nerve syndrome: fascicular motor lesions of median nerve trunk.

Authors:  Mirko Pham; Philipp Bäumer; Hans-Michael Meinck; Johannes Schiefer; Markus Weiler; Martin Bendszus; Henrich Kele
Journal:  Neurology       Date:  2014-01-10       Impact factor: 9.910

7.  T2-signal of ulnar nerve branches at the wrist in guyon's canal syndrome.

Authors:  Jennifer Kollmer; Philipp Bäumer; David Milford; Thomas Dombert; Frank Staub; Martin Bendszus; Mirko Pham
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

8.  Posterior interosseous neuropathy: Supinator syndrome vs fascicular radial neuropathy.

Authors:  Philipp Bäumer; Henrich Kele; Annie Xia; Markus Weiler; Daniel Schwarz; Martin Bendszus; Mirko Pham
Journal:  Neurology       Date:  2016-09-28       Impact factor: 9.910

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.